Contineum Therapeutics (CTNM) Stock Chart & Stock Price History $4.35 +0.51 (+13.28%) Closing price 04:00 PM EasternExtended Trading$4.23 -0.12 (-2.76%) As of 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Contineum Therapeutics Stock Price Performance The Contineum Therapeutics (CTNM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 79.32%, with a year-to-date return of -70.31%. In the past month, the stock has increased 19.18%, reflecting recent market activity. As of the latest close, Contineum Therapeutics traded at $3.84 with a market cap of $99.34 million and volume of 146,857 shares. Receive CTNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.97%1 Month Performance+19.18%3 Month Performance-5.84%Year-To-Date Performance-70.31%1 Year Performance-79.32% CTNM Stock Chart for Friday, July, 18, 2025 CTNM Chart by TradingView Contineum Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/17/2025$3.83$3.84+0.26%$4.03$3.80146,857 shs$99.34 million07/16/2025$3.77$3.83+1.59%$3.91$3.72115,055 shs$99.09 million07/15/2025$3.73$3.77+1.07%$3.92$3.77118,856 shs$97.53 million07/14/2025$3.92$3.73-4.85%$4.02$3.72181,147 shs$96.50 million07/11/2025$4.03$3.92-2.73%$4.03$3.8958,232 shs$101.41 million07/10/2025$4.01$4.03+0.50%$4.08$3.86114,680 shs$104.26 million07/09/2025$3.92$4.01+2.30%$4.19$3.90191,287 shs$103.75 million07/08/2025$3.81$3.92+2.89%$3.96$3.8373,153 shs$101.41 million07/07/2025$3.98$3.81-4.15%$3.99$3.7566,143 shs$98.57 million07/04/2025$3.98$3.98$4.07$3.86143,855 shs$102.83 million Get the Latest News and Ratings for CTNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/03/2025$4.00$3.98-0.62%$4.07$3.86143,855 shs$102.83 million07/02/2025$3.85$4.00+3.90%$4.20$3.85282,825 shs$103.48 million07/01/2025$3.97$3.85-3.02%$4.10$3.80292,338 shs$99.60 million06/30/2025$4.11$3.97-3.41%$4.11$3.78159,611 shs$102.71 million06/27/2025$4.01$4.11+2.49%$4.35$3.971.31 million shs$106.33 million06/26/2025$4.59$4.01-12.64%$4.64$3.86222,765 shs$103.74 million06/25/2025$4.53$4.59+1.32%$4.64$3.69366,951 shs$118.74 million06/24/2025$4.12$4.53+9.95%$4.76$4.15135,129 shs$117.19 million06/23/2025$4.76$4.12-13.45%$4.88$4.09188,816 shs$106.58 million06/20/2025$3.65$4.76+30.41%$4.87$3.71297,181 shs$123.14 million06/19/2025$3.65$3.65$4.05$3.5768,027 shs$94.43 million06/18/2025$3.93$3.65-7.12%$4.05$3.5768,027 shs$94.43 million06/17/2025$4.29$3.93-8.39%$4.49$3.9167,006 shs$101.68 million Related Companies ITOS Stock Chart ETON Stock Chart VIGL Stock Chart CYRX Stock Chart HUMA Stock Chart CKPT Stock Chart ATXS Stock Chart ARCT Stock Chart BNTC Stock Chart GOSS Stock Chart Receive CTNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTNM) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredSteve Jobs' Deathbed Secret Finally LeakedLeaked: Jobs’ Final Apple Project Exposed Bloomberg just leaked details of a secret project Steve Jobs set ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Contineum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTNM Stock Alerts